---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-087110"
form_type: "8-K"
ticker: "SLS"
cik: "0001390478"
company_name: "SELLAS Life Sciences Group, Inc."
filed_at: "2026-07-27T20:35:10+00:00"
generated_at: "2026-07-27T20:36:26.409496+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SELLAS loses arbitration against 3D Medicines; cash $138.3M as of June 30

## Summary
- Arbitration claims dismissed; company ordered to pay ~$1.0M in legal fees.
- 3D Medicines to continue GPS development; $191.5M in potential milestones remain, including $13.0M disputed.
- Preliminary unaudited cash and equivalents $138.3M as of June 30, 2026.

## SEC filing metadata
- accession: 0001104659-26-087110
- form_type: 8-K
- ticker: SLS
- cik: 0001390478
- company_name: SELLAS Life Sciences Group, Inc.
- filed_at: 2026-07-27T20:35:10+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1390478/000110465926087110/0001104659-26-087110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1390478/000110465926087110/tm2621415d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-087110
- JSON: https://secwatch.observer/filing/0001104659-26-087110.json
- Plain text: https://secwatch.observer/filing/0001104659-26-087110.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.